Related Experiment Video
Updated: Sep 11, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Exploring Adverse Event Associations of Predicted PXR Agonists Using the FAERS Database
Saki Yamada1, Yoshihiro Uesawa1
1Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Tokyo 204-8588, Japan.
Pregnane X receptor (PXR) activation is linked to cardiac risks. Machine learning identified PXR agonist activity in drugs associated with cardiovascular adverse events, aiding drug safety assessments.
Area of Science:
- Pharmacology
- Toxicology
- Computational Biology
Background:
- Pregnane X receptor (PXR) is a nuclear receptor regulating drug metabolism and physiological functions.
- The full impact of PXR activation on adverse events remains incompletely understood.
- PXR's role in drug-induced toxicity requires further investigation.
Purpose of the Study:
- To develop a machine learning model for predicting PXR agonist activity.
- To assess the association between PXR agonist activity and adverse drug events.
- To identify potential cardiovascular risks linked to PXR activation.
Main Methods:
- Developed a machine learning model to predict PXR agonist activity.
- Applied the model to drugs in the US Food and Drug Administration Adverse Event Reporting System (FAERS) database.
- Analyzed predicted PXR agonist-drug interactions against reported adverse events using statistical risk assessment (lnROR, -logp).
Main Results:
- The machine learning model successfully predicted PXR agonist activity.
- Statistically significant risks for multiple cardiac disorders were identified for PXR agonist-active drugs.
- Specific drug-cardiac event associations revealed elevated risk profiles.
Conclusions:
- PXR activation is implicated in cardiovascular adverse effects.
- Machine learning models can aid in predicting drug-induced cardiovascular risks.
- Early identification of PXR-mediated risks can enhance drug safety evaluations.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...